Matthew R. Dudgeon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Matthew R. Dudgeon has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Alec Powers
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
1 shared publication - Alexandra Young
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
1 shared publication - Amy Zeidan
Emory University School of Medicine, Atlanta, GA, USA
1 shared publication - Anna Q. Yaffee
Department of Emergency Medicine, Emory University School of Medicine, Atlanta, USA
1 shared publication - Camille Lin
Department of Family Medicine, Prisma Health Tuomey Hospital, Sumter, USA
1 shared publication - Jaysingh Brijkumar
Department of Infectious Diseases, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa
1 shared publication
Latest Publications
- Open Access
- 12 August 2026
- Published by MDPI AG in Epigenomes
- Vol. 10 (3) , 54
Longitudinal Changes in Inflammation-Related Methylation Risk Score for C-Reactive Protein Among People with HIV
Background/Objectives: Human immunodeficiency virus (HIV) infection is characterized by chronic systemic inflammation. Antiretroviral therapy (ART) can reduce persistent inflammation, as measured by C-reactive protein (CRP). The CRP methylation risk score (MRSCRP) acts as proxy for plasma CRP, but longitudinal changes in this score for people with HIV (PWH) before and after initiating ART have not been described. Methods: We evaluated a previously published MRSCRP in the Emory Twin Study (N = 352), testing its correlation with plasma CRP and CRP-responsive biomarkers, as well as associations with cardiometabolic traits using generalized estimating equations (GEEs). We then applied MRSCRP in the HIV AIDS Drug Resistance Surveillance Study (ADReSS) cohort (N = 440) to assess longitudinal changes before and after ART, using paired t-tests and linear mixed-effects models. Results: MRSCRP showed moderate correlation with CRP (r = 0.38) and other inflammatory biomarkers (r = 0.25–0.34). MRSCRP was associated with hypertension, type 2 diabetes, coronary artery disease, and obesity, and remained independently associated with obesity (odds ratio = 1.49) after adjusting for measured CRP. Z-score-standardized MRSCRP decreased by 0.254 standard deviation units between baseline and follow-up among PWH receiving ART, confirmed by linear mixed-effects models. Conclusions: MRSCRP showed associations with chronic inflammation and cardiometabolic diseases. The observed decline in MRSCRP following ART initiation may reflect changes in inflammatory status among PWH. These findings highlight the potential of MRSCRP as a marker of inflammation-related changes and comorbidity risk in PWH.
- 12 August 2026
- Published by MDPI AG in Epigenomes
- Vol. 10 (3) , 54
Open AccessLongitudinal Changes in Inflammation-Related Methylation Risk Score for C-Reactive Protein Among People with HIV
Background/Objectives: Human immunodeficiency virus (HIV) infection is characterized by chronic systemic inflammation. Antiretroviral therapy (ART) can reduce persistent inflammation, as measured by C-reactive protein (CRP). The CRP methylation risk score (MRSCRP) acts as proxy for plasma CRP, but longitudinal changes in this score for people with HIV (PWH) before and after initiating ART have not been described. Methods: We evaluated a previously published MRSCRP in the Emory Twin Study (N = 352), testing its correlation with plasma CRP and CRP-responsive biomarkers, as well as associations with cardiometabolic traits using generalized estimating equations (GEEs). We then applied MRSCRP in the HIV AIDS Drug Resistance Surveillance Study (ADReSS) cohort (N = 440) to assess longitudinal changes before and after ART, using paired t-tests and linear mixed-effects models. Results: MRSCRP showed moderate correlation with CRP (r = 0.38) and other inflammatory biomarkers (r = 0.25–0.34). MRSCRP was associated with hypertension, type 2 diabetes, coronary artery disease, and obesity, and remained independently associated with obesity (odds ratio = 1.49) after adjusting for measured CRP. Z-score-standardized MRSCRP decreased by 0.254 standard deviation units between baseline and follow-up among PWH receiving ART, confirmed by linear mixed-effects models. Conclusions: MRSCRP showed associations with chronic inflammation and cardiometabolic diseases. The observed decline in MRSCRP following ART initiation may reflect changes in inflammatory status among PWH. These findings highlight the potential of MRSCRP as a marker of inflammation-related changes and comorbidity risk in PWH.
- 24 May 2025
- Published by Springer Nature in Journal of Immigrant and Minority Health
- Vol. 27 (6) , 1035-1042
Characterizing Identifiers for Immigrant Populations in Electronic Health Records
The current use of identifiers to describe immigrant patients in Electronic Health Records (EHRs) is poorly described and lacks standardization, but nevertheless has broad implications related to clinical care and research of this population. We conducted interviews with stakeholders to discern strong identifiers for use to identify patients who have immigrated to the United States (U.S.). Language, country of origin, time in the U.S., and race/ethnicity were identified as effective, ethical, and acceptable for use. Limitations of each of these identifiers were noted, highlighting the need to use multiple identifiers in combination when describing patients in EHRs. The processes used to collect these identifiers in clinical settings and the ethical implications of using these identifiers must also be carefully considered. Our results highlight the need for standards related to documentation of immigrant patients in EHRs. Further research is also needed to validate the identifiers we have outlined, discern additional identifiers that are useful and acceptable in specific clinical and research contexts, and explore how strong identifiers can be operationalized in EHRs for clinical, research, and community engagement purposes.
- 24 May 2025
- Published by Springer Nature in Journal of Immigrant and Minority Health
- Vol. 27 (6) , 1035-1042
Characterizing Identifiers for Immigrant Populations in Electronic Health Records
The current use of identifiers to describe immigrant patients in Electronic Health Records (EHRs) is poorly described and lacks standardization, but nevertheless has broad implications related to clinical care and research of this population. We conducted interviews with stakeholders to discern strong identifiers for use to identify patients who have immigrated to the United States (U.S.). Language, country of origin, time in the U.S., and race/ethnicity were identified as effective, ethical, and acceptable for use. Limitations of each of these identifiers were noted, highlighting the need to use multiple identifiers in combination when describing patients in EHRs. The processes used to collect these identifiers in clinical settings and the ethical implications of using these identifiers must also be carefully considered. Our results highlight the need for standards related to documentation of immigrant patients in EHRs. Further research is also needed to validate the identifiers we have outlined, discern additional identifiers that are useful and acceptable in specific clinical and research contexts, and explore how strong identifiers can be operationalized in EHRs for clinical, research, and community engagement purposes.